NCT02913313 2025-04-20A Study of BMS-986207 Given Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Advanced Solid TumorsBristol-Myers SquibbPhase 1/2 Completed101 enrolled 34 charts